BioPharm International
October 01, 2011
Issue PDF
24
10
Examining the Outsourcing Relationship
October 01, 2011
Guest Editorial
24
10
It is important for all of us to be well versed in the new sciences that impact the development of protein therapeutics.
October 01, 2011
Features
24
10
A Q&A with Rick Hancock, president of Althea Technologies. This article contains bonus online material.
October 01, 2011
Features
24
10
The BioPlan Associates 8th annual survey identifies key outsourcing concerns of sponsor companies.
October 01, 2011
Features
24
10
An in-depth characterization of maize-derived trypsin revealed an unusual nonconsensus N-linked glycosylation.
October 01, 2011
Burrill on Biotech
24
10
Volatile Markets Take a Toll on Life-Sciences Initial Public Offerings
October 01, 2011
Features
24
10
A survey provides insight into drug companies' plans for spending on outsourced services. This article contains bonus online material.
October 01, 2011
Regulatory Beat
24
10
Manufacturers fund research and reduce prices to tackle diseases around the world.
October 01, 2011
Perspectives on Outsourcing
24
10
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
October 01, 2011
Features
24
10
The authors provide insight into microRNA biology, and the simplicity of anti-miR oligonucleotide drug delivery.
October 01, 2011
Final Word
24
10
Knowing in advance what you need can make a huge difference in a sponsor company's success.